CD4 and rheumatoid arthritis: In contrast, we show a significantly higher percentage of type 1 CD8+IFNγ+ SF T cells from patients with early seropositive RA compared with both the seronegative UIA and SpA groups, and in CD4+IFNγ+ SF T cells in early RA versus seronegative UIA.